Drug Shortage Report for TRIESENCE
| Report ID | 157590 |
| Drug Identification Number | 02368676 |
| Brand name | TRIESENCE |
| Common or Proper name | TRIESENCE 1ML SUSP. |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TRIAMCINOLONE ACETONIDE |
| Strength(s) | 40MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVITREAL INTRAVITREAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-03-08 |
| Actual start date | 2022-04-12 |
| Estimated end date | 2025-02-15 |
| Actual end date | 2025-02-05 |
| Shortage status | Resolved |
| Updated date | 2025-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v25 | 2025-02-06 | English | Compare |
| v24 | 2025-02-05 | French | Compare |
| v23 | 2025-02-05 | English | Compare |
| v22 | 2025-02-05 | French | Compare |
| v21 | 2025-02-05 | English | Compare |
| v20 | 2024-12-19 | French | Compare |
| v19 | 2024-12-19 | English | Compare |
| v18 | 2024-11-18 | French | Compare |
| v17 | 2024-11-18 | English | Compare |
| v16 | 2024-06-21 | French | Compare |
| v15 | 2024-06-21 | English | Compare |
| v14 | 2024-03-21 | French | Compare |
| v13 | 2024-03-21 | English | Compare |
| v12 | 2023-08-30 | French | Compare |
| v11 | 2023-08-30 | English | Compare |
| v10 | 2022-10-26 | French | Compare |
| v9 | 2022-10-26 | English | Compare |
| v8 | 2022-04-13 | English | Compare |
| v7 | 2022-04-12 | French | Compare |
| v6 | 2022-04-12 | English | Compare |